On November 22, the HPBeter multidisciplinary congress brought together diverse group of healthcare professionals. This congress day was organized to discuss, inspire and improve research projects and healthcare in the hepatopancreatobiliary (HPB) field.

The day was structured into four thematic sessions: colorectal liver metastases, primary liver diseases, and both malignant pancreatic and biliary diseases and benign HPB conditions. Each session was moderated by chairs who guided the discussions. Presentations ranged from clinical trials to fundamental research, alternated with healthcare pathways, case presentations and healthcare challenges. This comprehensive approach ensured that participants left with both a deeper understanding of the latest innovations and practical insights for daily practice.

It was a very well visited day, attracting healthcare professionals as researchers, medical specialists, residents (AIOS/Fellows), and nurse practitioners from all different fields. This year we also saw an increased attendance of care professionals from peripheral hospitals. The engagement and enthusiasm from this broad spectrum of participants contributed to the success of the day.

The day ended with a keynote presentation by Professor Sjoerd Repping, chairman of ZE&GG (Zorgevaluatie en Gepast Gebruik) at the Zorginstituut Nederland. His talk was both confronting and inspiring, challenging us to critically reflect on the type of research we conduct and the barriers we face when implementing our study results. By sharing his team’s work on healthcare evaluation and appropriate use, Sjoerd Repping offered insights and inspiration for the future.

Prof. Sjoerd Repping

HPBeter 2024 was a successful day, the organizing committee would like to thank AGEM and CCA for making this day possible.

Follow Cancer Center Amsterdam on LinkedIn